A pharmaceutical company was deciding whether to acquire a technological asset to help patients adhere to medication. The client came to buzzback seeking to explore current use of technology and assess opportunity through a study of patients, HCPs, and payers to inform digital strategy within the category and to guide their decision.
A holistic approach with qualitative and quantitative blended methodology – study of patients, HCPs, and payers:
-Quantitative Assessment
-e-Collage
-Blobs Exercise
The research identified business case and maximum price for the acquisition as well as determined how stakeholders saw value. We identified specific patient profiles and uncovered need for cost/benefit analysis.
Interactive Stim allows us to amplify the scale for business decisions.
Full-Service
About buzzback
